India’s specialty chemicals story gets a fresh public-market chapter this week. The Prasol Chemicals IPO opened for subscription on 8 September 2026 and closes on 10 September 2026, seeking to raise ₹500 crore through a book-built mainboard offer. For newsd.in readers weighing whether the issue deserves attention, here is a grounded look at the company’s chemistry-led business, the offer structure and the schedule from bidding to listing.
Founded in 1992, Prasol is a forward-integrated manufacturer of acetone-based and phosphorus-based specialty chemicals — niche compounds produced in smaller volumes for specific industrial applications, unlike bulk commodity chemicals. The scale of its operation is notable:
The chemistries involved are complex and differentiated, which raises the barrier for competitors attempting to replicate the product range — a structural advantage that specialty chemical investors tend to prize.
The offer comprises a fresh issue of ₹80 crore (11,83,431 shares) and an offer for sale of ₹420 crore (62,13,006 shares) by existing shareholders, each of ₹2 face value. Net proceeds from the fresh portion are earmarked primarily for debt repayment and corporate purposes. The price band stands at ₹643 to ₹676 per share with a lot size of 22 shares, putting the minimum retail application at ₹14,872 at the upper band.
September 2026 has turned into a crowded month for primary issuance, with several mainboard and SME offers running overlapping windows. Applicants juggling more than one application often find it useful to view the entire calendar in one place, and the upcoming ipo section on Kotak Neo lays out scheduled and awaited offers with their expected sizes and dates, which helps in planning how much capital to keep unblocked across simultaneous bids.
Institutional interest in this particular issue showed up early: the company raised ₹150 crore from 14 anchor investors on 7 September 2026 at ₹676 per share, with domestic mutual funds taking the largest slice of the anchor book.
DAM Capital Advisors is the book-running lead manager, and KFin Technologies is the registrar handling applications and allotment.
Prasol’s recent performance shows meaningful acceleration. Revenue grew from ₹1,015.54 crore in FY25 to ₹1,237.85 crore in FY26, while profit after tax nearly doubled from ₹43.57 crore to ₹83.12 crore. Improving profitability on a growing top line usually signals better product mix or operating leverage — both worth verifying in the prospectus rather than assuming.
Two facilities carry the entire production load, so plant-level concentration is a genuine operational risk, and utilisation rates differ sharply between the sites. Raw material linkage to acetone and phosphorus derivatives exposes margins to feedstock price cycles. And with ₹420 crore of the ₹500 crore being an offer for sale, the bulk of proceeds flows to selling shareholders rather than the business. The red herring prospectus filed with SEBI carries the complete risk disclosure, and grey market premium chatter — whatever direction it points — remains an informal indicator with no regulatory standing.
This website uses cookies.